Detalhe da pesquisa
1.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
N Engl J Med
; 384(9): 795-807, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306283
2.
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.
Clin Infect Dis
; 76(3): e439-e449, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608504
3.
Evaluating SARS-CoV-2 Saliva and Dried Blood Spot Surveillance Strategies in a Congregate Population.
Emerg Infect Dis
; 29(9): 1925-1928, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37579513
4.
An Outbreak of Covid-19 on an Aircraft Carrier.
N Engl J Med
; 383(25): 2417-2426, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33176077
5.
Remdesivir for the Treatment of Covid-19 - Final Report.
N Engl J Med
; 383(19): 1813-1826, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32445440
6.
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial.
Ann Intern Med
; 175(12): 1716-1727, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442063
7.
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity.
Clin Infect Dis
; 74(5): 897-900, 2022 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117878
8.
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.
Emerg Infect Dis
; 28(4): 828-832, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35203111
9.
Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19.
Ann Intern Med
; 174(8): 1151-1158, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125574
10.
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries.
J Infect Dis
; 224(9): 1462-1472, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331541
11.
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection.
J Infect Dis
; 224(12): 2010-2019, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34673956
12.
Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
Clin Infect Dis
; 73(11): e4312-e4320, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32898271
13.
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
BMC Infect Dis
; 21(1): 544, 2021 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34107889
14.
Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients.
Value Health
; 21(2): 210-218, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29477403
15.
Temperature effects in contacts between a metal and a semiconductor nanowire near the degenerate doping.
Nanotechnology
; 2018 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29424703
16.
A Case of Early Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Clin Infect Dis
; 73(9): e2827-e2828, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949240
17.
SARS-CoV-2 Infection Risk Among Active Duty Military Members Deployed to a Field Hospital - New York City, April 2020.
MMWR Morb Mortal Wkly Rep
; 70(9): 308-311, 2021 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33661864
18.
Polarity-driven nonuniform composition in InGaAs nanowires.
Nano Lett
; 13(11): 5085-9, 2013 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24134612
19.
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera.
bioRxiv
; 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712124
20.
SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-up.
PLoS One
; 19(4): e0297481, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626117